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Abstract POU3F4 encodes a POU-domain transcription
factor required for inner ear development. Defects in
POU3F4 function are associated with X-linked deafness
type 3 (DFN3). Multiple deletions affecting up to *900-kb
upstream of POU3F4 are found in DFN3 patients, sug-
gesting the presence of essential POU3F4 enhancers in this
region. Recently, an inner ear enhancer was reported that is
absent in most DFN3 patients with upstream deletions.
However, two indications suggest that additional enhancers
in the POU3F4 upstream region are required for POU3F4
function during inner ear development. First, there is at
least one DFN3 deletion that does not eliminate the
reported enhancer. Second, the expression pattern driven
by this enhancer does not fully recapitulate Pou3f4
expression in the inner ear. Here, we screened a 1-Mb
region upstream of the POU3F4 gene for additional cis-
regulatory elements and searched for novel DFN3 muta-
tions in the identified POU3F4 enhancers. We found sev-
eral novel enhancers for otic vesicle expression. Some of
these also drive expression in kidney, pancreas and brain,
tissues that are known to express Pou3f4. In addition, we
report a new and smallest deletion identified so far in a
DFN3 family which eliminates 3.9 kb, comprising almost
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exclusively the previous reported inner ear enhancer. We
suggest that multiple enhancers control the expression of
Pou3f4 in the inner ear and these may contribute to the
phenotype observed in DFN3 patients. In addition, the
novel deletion demonstrates that the previous reported
enhancer, although not sufficient, is essential for POU3F4
function during inner ear development.
Introduction
POU-domain genes encode a large family of evolutionary
conserved transcription factors that contain two character-
istic DNA-binding domains, a homeobox and a POU
domain. They play multiple roles during animal develop-
ment (reviewed in Phillips and Luisi 2000; Ryan and
Rosenfeld 1997). Pou3f4 (also know as Brn4), one of the
members of this family, has a complex and dynamic
expression pattern in different vertebrate tissues such as the
developing inner ear, brain, neural tube, kidney and pan-
creas (de Kok et al. 1996; Heller et al. 2004; Phippard et al.
2000; Witta et al. 1995). Studies in Xenopus indicate that
Pou3f4 (originally named Xlpou2) has the potential to
transform epidermis to neural fate during early develop-
ment (Witta et al. 1995). Moreover, mouse models
demonstrate that this gene is essential for inner ear devel-
opment (Phippard et al. 2000; Phippard et al. 1999). In
humans, several deletions, inversions and point mutations
indicate that POU3F4 is associated with the most common
form of X-linked non-syndromic deafness, deafness type 3
(DFN3) (Bitner-Glindzicz et al. 1995; de Kok et al. 1995a,
b, 1996, 1997). Indeed, DFN3 patients show inner ear
malformations that are similar to those found in mice
lacking Pou3f4 expression (Phippard et al. 1999, 2000),
indicating a conserved requirement of this gene for inner
ear development in mammals and probably in other ver-
tebrates as well.
In addition to coding sequences, some non-coding
sequences display high conservation between evolutionary
distant species. Their evolutionary conservation is sug-
gested to underlie essential regulatory functions. Interest-
ingly, the human POU3F4 gene is located on the X
chromosome, in a 3-Mb gene desert region enriched for
highly conserved non-coding regions (HCNRs). Gene
deserts enriched for HCNRs is a genomic feature charac-
teristic of developmental genes with tightly regulated
expression patterns (reviewed in Alonso et al. 2008).
Indeed, many different studies have shown that HCNRs are
enriched in cis-regulatory elements (reviewed in Alonso
et al. 2008). Several DFN3 patients and families contain
deletions that do not affect the transcribed region of
POU3F4 but instead remove different portions of DNA in
the desert genomic region upstream of the gene (Cremers
et al. 2008; de Kok et al. 1996) (Fig. 1a). The detailed
genomic analysis of these deletions prompted to define a
critical region for DFN3 *920-kb upstream of the gene
(de Kok et al. 1996) and to propose the presence of cis-
regulatory sequences essential for POU3F4 expression in
the developing inner ear in this critical region (de Kok et al.
1996). Most of the identified microdeletions encompass a
critical region of *8 kb from a 13-kb EcoRI fragment
(patient 2540) (Cremers et al. 2008; de Kok et al. 1996).
Indeed, a recent report showed that, in mouse transgenic
assays, a human 3.4-kb DNA fragment containing a HCNR
located within this 13-kb fragment can promote expression
in several inner ear structures derived from the otic mes-
enchyme (Ahn et al. 2009). This includes the temporal
bone, spiral ligament, and the mesenchyme underlying the
sensory epithelium of the utricle, saccule and semicircular
canals (Ahn et al. 2009), most being structures affected in
DFN3 patients or in mouse models for this disease (de Kok
et al. 1995b; Phippard et al. 1999, 2000). However, the
expression pattern promoted by this HCNR did not fully
recapitulate that of the endogenous Pou3f4 gene (Ahn et al.
2009). This, together with the fact that not all 50 deletions
remove the critical 13-kb interval (Cremers et al. 2008; de
Kok et al. 1996), indicate that other important inner ear
enhancers are likely to contribute to POU3F4 expression in
this territory.
Here, we report the enhancer survey of multiple HCNRs
located in a region of 1-Mb upstream of Xenopus Pou3f4 in
both Xenopus and zebrafish by using transgenic assays. We
identify three novel Pou3f4 regulatory regions capable of
activating expression in the developing otic vesicle, as well
as in other Pou3f4 expression domains. These novel regu-
latory regions are likely contributing to POU3F4 inner ear
expression and are therefore candidate regions to be
affected in DFN3 patients. In addition, we identify a new
Fig. 1 Localization of DFN3 deletions and HCNRs in the upstream
genomic region of POU3F4. Green arrows show the position of the
identified enhancers. a Deletion map within 1.5 Mb around POU3F4
as reported previously (de Kok et al. 1996; Cremers et al. 2008).
Dashed lines represent the deleted regions in each patient. The red
box marks the 13-kb EcoRI fragment in which the 2540 8-kb deletion
is located. b Vista view showing the distribution of HCNRs within
1-Mb upstream of POU3F4. Shown from top to bottom are mouse
versus human, chicken versus human and Xenopus tropicalis versus
human global alignments. Coloured peaks (purple coding, pink non-
coding) indicate regions of at least 100 bp and 75% similarity. Red
dots are HCNRs with no enhancer activity in Xenopus assays. Green
arrows point at the HCNRs that showed enhancer activity (also shown
with green dots). Their genomic positions are depicted in green. The
red box marks the 13-kb EcoRI fragment in which the 2540 8-kb
deletion is located. c Close-up of this 13-kb EcoRI fragment. Below is
shown the new deletion identified in this work (dotted line). The blue
line shows the region that was reported to have inner ear enhancer
activity in mouse transgenic assays (Ahn et al. 2009)
c
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DFN3 family that contains a minimal deletion of 3.9 kb
that precisely removes the reported HCNR with inner ear
enhancer activity within the 13-kb critical interval. These
results support the idea that, despite the existence of other
otic vesicle enhancers, this one is critical for POU3F4
activity in the developing inner ear.
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Materials and methods
Patients
Family W06-205 with five affected males is shown in the
pedigree from Fig. 4a. The hearing loss in four of them was
already severe in childhood. For subject II.4 pure tone
thresholds have never been determined. He was said to be
born deaf but he developed some speech after big efforts of
his mother. Individual II.6 is profoundly hearing impaired
and did not develop speech. In patient III.2, the hearing
loss is stable and severe to profound and speech develop-
ment was very poor. Only for individuals IV.1 and IV.2,
audiological data are available from childhood. The hear-
ing loss of subject IV.1 was moderate at the age of
27 months and severe at 6 years. In individual IV.2, the
hearing loss was less severe. He had moderate hearing loss
at 10 and 12 years of age, with a significant air bone gap in
the lower frequencies. He underwent stapes surgery at
12 years of age and stapes gusher occurred during surgery.
There are no indications for hearing loss in any of the
female mutation carriers of generations II–IV but audio-
metry has not been performed.
All patients or their legal representatives gave written
informed consent for the study.
Genetic analyses
Genomic DNA of family members was isolated from
peripheral blood samples by a standard salting out procedure
(Miller et al. 1988). Analysis of 14 STR markers uniformly
dispersed over the X chromosome was performed using
standard methodology on an ABI 3130 DNA sequencer
(Applied Biosystems, CA, USA). DNA sequencing of the
complete POU3F4 coding region was done by PCR ampli-
fication in overlapping fragments and sequencing using the
same ABI sequencer. Sequences of primers employed to
characterize the deletion in family W06-205 by amplifica-
tion of fragments of the proximal region are provided in
Supplementary Table 1. DMSO was added to 10% of the
volume of the PCR for the amplicons 4 and 5. Amplification
was performed with Phusion High-Fidelity DNA Polymer-
ase (New England Biolabs, MA, USA). Primers have been
designed with Primer3plus (http://www.bioinformatics.nl/
cgi-bin/primer3plus/primer3plus.cgi).
Functional reporter analyses in Xenopus and zebrafish
All HCNRs were selected with the vista browser (http://
pipeline.lbl.gov/cgi-bin/gateway2) using the default
parameters (regions of at least 100 bp and 70% similarity).
HCNRs were amplified by PCR from Xenopus tropicalis
genome using the primers listed in Supplementary Table 2.
The PCR fragments were subcloned in PCR8/GW/TOPO
(Invitrogen, CA, USA) vector and, using the gateway
technology (Invitrogen, CA, USA), transferred to the cor-
responding destination enhanced green fluorescent protein
(EGFP) reporter vectors recently described (Bessa et al.
2009; Pittman et al. 2009) for I-SceI or Tol2 mediated
transgenesis in Xenopus or zebrafish, respectively.
Embryos expressing GFP were analyzed by observation of
fluorescence. Xenopus embryos were then fixed and pro-
cessed for whole mount in situ hybridization to detect GFP
mRNA.
Xenopus and zebrafish in situ hybridization
EGFP antisense RNA probes were prepared from cDNAs
using digoxigenin (Roche, Basel, Switzerland) as label.
Xenopus and zebrafish specimens were prepared, hybridi-
zed and stained as described (Harland 1991; Tena et al.
2007).
Results
Identification of novel Pou3f4 cis-regulatory elements
We have examined the enhancer activity of multiple
HCNRs present within 1-Mb upstream of Pou3f4 by using
Xenopus and zebrafish transgenic assays. The identified
HCNRs were conserved from human to frog and located in
the genomic region in which most DFN3 deletions map
(Fig. 1a). We amplified 16 HCNRs (Supplementary
Table 2) from the Xenopus tropicalis genome and cloned
them in the PCR8/GW/TOPO vector. We have named
these HCNRs according to the position of their human
orthologous sequences, shown in kilobases, on the X
chromosome of the NCBI human genome assembly 18.
The cloned HCNRs were transferred to vectors compatible
with SceI or Tol2 mediated transgenesis in Xenopus or
zebrafish, respectively (Bessa et al. 2009; Pittman et al.
2009). In these vectors, the HCNRs are placed upstream of
the proximal promoter of the Xenopus or zebrafish gata2
gene driving the expression of the EGFP reporter gene.
This promoter alone has no activity during embryogenesis
neither in zebrafish nor Xenopus.
We first generated transient Xenopus transgenic embryos
for all 16 HCNRs. From them, only five of these HCNRs
(81675, 81728, 82478, 82637, and 82646; Fig. 1b) promoted
reproducible reporter gene expression in different transgenic
animals. All of them were active in a subset of regions
expressing the endogenous Pou3f4 gene (Fig. 2). We con-
firmed the enhancer activity of these five HCNRs by gene-
rating different stable zebrafish transgenic lines for each
region by using the same Xenopus genomic sequences. For
414 Hum Genet (2010) 128:411–419
123
all five HCNRs, we observed equivalent reporter gene
expression in zebrafish as compared to Xenopus (Fig. 2) in
several domains, further confirming its specificity. In
addition to element HCNR 81728, which is located 922-kb
upstream of POU3F4 and has recently been shown to be
active in the otic capsule in mouse transgenic assays (Ahn
et al. 2009), the HCNRs located at positions 81675 (970-kb
upstream), 82478 (170-kb upstream) and 82637 (12-kb
upstream) promoted inner ear expression of EGFP in both
Xenopus and zebrafish models (Fig. 2). The expression of
the HCNR at 81675 was almost completely confined to the
developing ear, with low background expression in the
branchial arch and the eye in Xenopus embryos (Fig. 2a, b).
In contrast, elements 82478 and 82637 also promoted EGFP
expression in the midbrain/hindbrain boundary that is most
prominently visible in the zebrafish transgenic lines
(Fig. 2e–h). In addition, HCNR 82478 was also found to be
active in the kidney and the pancreas (Fig. 2e, f, l). These
tissues are all known to express Pou3f4 (Fig. 2k) (de Kok
et al. 1996; Heller et al. 2004; Phippard et al. 2000; Witta
et al. 1995). Finally, the HCNR at position 82646 induced
expression in the brain and spinal cord (Fig. 2i, j). This
expression pattern is identical to that found in mouse trans-
genic assays with a 6-kb sequence from the mouse Pou3f4
promoter region that contains the orthologous sequence
(Heydemann et al. 2001).
During inner ear development, Pou3f4 is expressed in
the periotic mesenchyme (Phippard et al. 1998, 1999). To
better characterize the expression pattern promoted by the
new identified enhancers in the inner ear domain, we per-
formed transverse sectioning of transgenic zebrafish
embryos carrying the different enhancers at 65–75 h post
fertilization. Enhancers at position 81675 and 82637, as
well as the previous characterized at 81728, promote
expression in the periotic mesenchyme (Fig. 3a, b, d, red
arrows). Unexpectedly, all these enhancers were active in
the otic epithelium (Fig. 3, white arrows), a tissue that
seems to be devoid of Pou3f4 expression (Phippard et al.
1998, 1999). This was also occurring for the enhancer
within HCNR 82478, which was not promoting expression
in the periotic mesenchyme but strongly in the pronephros
(Fig. 3c, yellow arrows). It is possible that the activity of
all these enhancers in the otic epithelium in transgenic
embryos reflects a low level of the endogenous Pou3f4
expression in these cells. Alternatively, the activity in these
regions may only be observed when the Pou3f4 enhancers
are not in their genomic context with other cis-regulatory
elements. Interestingly, in mouse transgenesis assays, the
enhancer at position 81728 also drives expression in some
epithelial cells of the otic vesicle (Ahn et al. 2009).
Characterization of a new DFN3 deletion
To determine the possible association of deletions in
HCNRs 81675, 81728, 82478, and 82637 with a DFN3
phenotype, we tested five index cases for deletions in these
Fig. 2 Expression patterns promoted by different Pou3f4 HCNRs in
Xenopus and zebrafish transgenic assays. Xenopus embryos show in situ
hybridization to detect EGFP mRNA in fixed transgenic animals while
zebrafish embryos show EGFP in living transgenic specimens. All
panels, except (l) that show a dorsal view, are lateral views of transgenic
Xenopus (a, c, e, g, i) at stage 35 or transgenic zebrafish (b, d, f, h, j, l) at
36–72-h post fertilization (hpf). The position of the HCNRs in the human
genome is shown in the upper right corner of each panel. Different tissues
are pointed at with coloured arrowheads. Blue otic vesicle, red midbrain,
orange hindbrain, yellow kidney and purple pancreas. Note the
equivalent patterns promoted by each HCNR in Xenopus and zebrafish
transgenic embryos. k Expression pattern of Xenopus Pou3f4
Hum Genet (2010) 128:411–419 415
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HCNRs. Mutation analysis of the protein-coding region of
POU3F4 did not reveal any putatively pathogenic muta-
tions in these patients. Only in the proband of family
W06-205 an indication for a deletion was obtained for one
of the HCNRs, namely 81728 which is located *920-kb
upstream of POU3F4 within the 13-kb EcoRI fragment
known to harbour an *8-kb deletion (patient 2540) (de
Kok et al. 1996). Family W06-205 of Greek origin pre-
sented with mixed hearing loss and segregation in the
family was compatible with X-linked inheritance (Fig. 4a).
Linkage analysis with STR markers across the X chro-
mosome revealed linkage to a region containing the
POU3F4 gene (Xq21.1), with a maximum LOD score of
2.1. The characterization of the deletion was initiated by
using five sets of primers for PCR (1–5; Supplementary
Table 2) in patient II.6, his mother (I.2) and a control
individual. The amplicons cover the 13-kb EcoRI fragment
containing the deletion in patient 2540. All primer sets
revealed a PCR fragment of the expected size in all three
individuals except primer set 2 with which no amplification
occurred in the individual II.6 (data not shown). Subse-
quently, three series of PCR primers (a–f, I–IV, and D;
Supplementary Table 2) were developed to determine the
breakpoint. With primer set D, we amplified a fragment of
*400 bp in the patient, a fragment of the same length in
the carrier female and in addition a fragment of the
expected size of*4.3 kb in both the carrier and the control
individual. By sequencing the 400-bp breakpoint spanning
PCR fragment, the size of the deletion could be determined
to be 3,902 bp (Fig. 4b) encompassing nucleotides
81727184–81731085 (Human genome assembly 18). This
deletion segregated with the disease in the family as was
tested by PCR with primer set D. In all patients and car-
riers, the 400-bp fragment could be amplified but not in
healthy males or in spouses of the carriers (Fig. 4a). Carrier
statuses of females who are not obligate carriers are not
shown for privacy reasons. Primer set D did not reveal
fragments of aberrant size in 100 normal hearing Greek
males or in 50 control females. The 3.9-kb region that is
deleted in affected males contains HNCR 81728 that is
present in the 13-kb region that encompasses the smallest
deleted region known so far (patient 2540) (Fig. 1c).
Moreover, the reporter construct used in the paper by Ahn
et al. (2009) contain a 3,370-bp genomic region that almost
completely encompass the deletion we have identified.
Discussion
Breakpoint analysis of multiple deletions in different
DFN3 patients suggests that cis-regulatory elements
essential for POU3F4 expression and inner ear develop-
ment are located within *900-kb upstream of the gene (de
Kok et al. 1996). Since most DFN3 deletions include the
genomic fragment deleted in DFN3 patient 2540 (de Kok
et al. 1996), an essential enhancer should be present within
the 13-kb region that contains this *8-kb deletion.
Accordingly, an inner ear enhancer at HCNR 81728 was
recently reported (Ahn et al. 2009). Here, we show that
HCNR 81728 is functionally conserved in Xenopus and
zebrafish. Moreover, the newly identified deletion, that
precisely remove this HCNR and almost no additional
neighbouring DNA, further demonstrates that this regula-
tory element is essential for POU3F4 function during inner
ear development. Nevertheless, the fact that there is one
DFN3 deletion (II/7) that removes about 800-kb upstream
of the gene but keeps the enhancer 81728 intact (Cremers
et al. 2008; de Kok et al. 1996) (Fig. 1a), suggests that this
enhancer, although essential, is not sufficient for POU3F4
expression and function during ear development. In the
original report (de Kok et al. 1996), the II/7 deletion was
uncorrectly depicted to be associated with a paracentric
inversion which was later corrected (Cremers et al. 2008).
Indeed, the paracentric inversion is associated with the
deletion G8314 and not with II/7, as shown here (Fig. 1a).
The existence of additional otic vesicle enhancer is further
supported by the expression promoted by HCNR 81728
Fig. 3 Transverse sections at the level of the otic vesicle of
65–75 hpf embryos showing the expression patterns promoted by
the different Pou3f4 HCNRs in stable zebrafish transgenic lines. All
panels show in situs hybridization to detect EGFP mRNA in fixed
embryos from the different transgenic lines. Note that enhancers at
positions 81675 (a), 81728 (b) and 82637 (d) promoted expression,
although in somehow different areas, in the periotic mesenchyme (red
arrows). In addition, all enhancers are active in the otic epithelium
(white arrows) and enhancer 82478 (c) is, in addition, active in the
developing kidneys (yellow arrows)
416 Hum Genet (2010) 128:411–419
123
which does not fully reproduce the Pou3f4 pattern in the
developing ear (Ahn et al. 2009).
By analyzing the activity of 15 additional HCNRs
present within 1-Mb upstream of POU3F4, we have found
three novel inner ear enhancers at 970-, 170- and 12-kb
upstream of the gene. This further suggests that the
expression of POU3F4 during inner ear development likely
depends on several regulatory elements. In addition to the
identified enhancers distributed along this vast 1-Mb
genomic interval, others may exist in less conserved non-
coding sequences or in regions not conserved at all, as has
been shown for other loci (McGaughey et al. 2008). The
contribution of enhancers other than HCNR 81728 to
POU3F4 function during inner ear development may be
significant, as can be inferred from deletion II/7 (Fig 1a).
Evaluation of the clinical information provided for family
W06-205 and the families with larger and overlapping or
non-overlapping deletions did not reveal indications for a
correlation between the severity of the hearing loss and the
size of the deletion and/or the number of the ear HCNRs
located in the deletion. This is further corroborated by the
differences in the severity of the hearing impairment
between affected males in family W06-205. Also, the
hearing loss in family II/7 in which HCNR 81728 is present
was described to be severe in all affected males with no or
minimal speech development (Robinson et al. 1992).
Therefore, we can conclude that the presence of HCNR
81728 is essential but not sufficient for normal ear function.
Some of the studied enhancers not only promote
expression in the developing inner ear but also in other
Pou3f4 expressing tissues such as the brain, kidney and
pancreas. In addition, we have confirmed the presence of a
neural enhancer in a HCNR positioned at 3-kb upstream of
the gene, which was previously detected in mouse trans-
genic assays (Heydemann et al. 2001). These results indi-
cate that, as has been found for many other developmental
genes (see for example de la Calle-Mustienes et al. 2005
and Jeong et al. 2006), the dynamic Pou3f4 expression
pattern is determined by multiple cis-regulatory elements,
being some of them partially redundant.
Fig. 4 Genetic analysis of
family W06-205. a Pedigree of
family W06-205 and
segregation of the deletion in
the family. Filled squares
represent DFN3 males.
D deletion, ? wildtype. The
genotype of females who are not
obligate carriers has not been
indicated for privacy reasons.
b Sequence chromatogram
showing the deletion
breakpoints in patient II.6.
Above this chromatogram, the
deletion is schematically
indicated
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Why developmental genes, such as POU3F4, often
possess multiple cis-regulatory elements that promote
expression in partially overlapping domains? A recent
report demonstrates that, in Drosophila, redundant
enhancers become essential under stressing conditions.
These results strongly suggest that redundant cis-regulatory
elements contribute to phenotypic robustness under envi-
ronmental and genetic variability (Frankel et al. 2010).
Therefore, the novel regulatory elements that are likely to
contribute to the expression of POU3F4 in the inner ear
may well carry small deletions or point mutations in DFN3
patients in which no POU3F4 point mutations, deletions or
major genomic rearrangements have been detected so far.
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